Part 3 of 3.
My guest for this week’s episode is Kittu Kolluri, Founder and Managing Director of Neotribe Ventures, an early- and growth-stage venture capital firm investing in companies that solve hard technical problems and disrupt non-traditional industry sectors. Neotribe is led by a team of serial entrepreneurs with a track record of supporting and advising startups from seed round to IPO. As a Silicon Valley veteran with a career spanning three decades, Kittu has had numerous roles before his time at Neotribe Ventures. Some highlights include working as an engineer at Silicon Graphics, co-founding Healtheon/WebMD, being the founder and CEO of Neoteris, and investing in over four dozen successful companies as a general partner at NEA.
Join us for the conclusion to the conversation with Kittu as he discusses working at the VC firm NEA and how his risky initial investment paid off after the company sold for over a billion dollars. His thoughts on sourcing opportunities and the differences between being a leader in a venture and a leader at a company. Kittu also discusses his investment philosophy as well as the values that he instilled in Neotribe Ventures. We also cover the personal and professional struggles that Kittu had to overcome while founding Neotribe. Lastly, Kittu discusses his take on why personal networks are critically important for long-term success. Please enjoy my conversation with Kittu Kolluri.
Find Our Guest, Kittu Kolluri, at these links: https://www.linkedin.com/in/kittukolluri/ https://www.neotribe.vc/ Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/joncheehttps://www.excedr.comTimestamps:00:20 Intro
01:15 Episode starts, starting at NEA and learning venture capital is about influence/control
04:07 Raising money at a Seed Stage, proof of value and proof of market, setting up a sales module
07:10 Sourcing opportunities, the differences between being a leader at a venture and a leader at a company
08:48 Partnership model differences in venture capital
10:33 First risky investment in Weatherbuild, growing his reputation with its billion-dollar success
14:00 Ranking the importance of product, market, and team before writing the check
15:38 Knowing when to start Neotribe, Neotribe as a “passionate rage against the status quo”
17:23 Pillars of Value at Neotribe and how they work with companies, building trust with entrepreneurs without feeling judged
20:45 Raising the first VC fund, the difficulties of building a company with personal struggles, the importance of a support network
26:44 Success is a function of two things, why a CEO can be considered an investor in their own company
29:16 The differences between operators and Venture Capitalists, optimizing customer acquisition
35:00 Outro
Social & WebsiteLinkedIn:
https://www.linkedin.com/company/excedr/ Youtube:
https://www.youtube.com/@excedr Instagram:
https://www.instagram.com/excedr_inc Twitter:
https://twitter.com/ExcedrInc Facebook:
https://www.facebook.com/excedr TikTok:
https://www.tiktok.com/@excedr Podcast Website:
https://www.thebiotechstartupspodcast.com/ Enriched Notes:
Topics Mentioned:Fooled By Randomness by Nassim Taleb
https://en.wikipedia.org/wiki/Fooled_by_Randomness Thinking in Bets by Annie Duke
https://www.amazon.com/Thinking-Bets-Making-Smarter-Decisions/dp/0735216355Go long or go short? A VC reveals when it’s time to sell and how to maximize buyer interest by Kittu Kolluri
https://techcrunch.com/2023/02/22/go-long-or-go-short-a-vc-reveals-when-its-time-to-sell-and-how-to-maximize-buyer-interest/ Top VC Firms for Biotechs
https://www.excedr.com/blog/top-vc-firms-for-biotech VC Term Sheets
https://www.excedr.com/resources/venture-capital-term-sheets VC Term Sheet Clauses: A Glossary of Key Terms
https://www.excedr.com/resources/vc-term-sheet-clauses-and-terms What are Your Funding Options
https://www.excedr.com/resources/biotech-startup-funding-options Getting Funding for Lab Research
https://www.excedr.com/blog/how-to-get-funding-for-lab-research Post vs Pre Money Valuations
https://www.excedr.com/resources/pre-money-vs-post-money Marketing and Sales for Startups
https://www.excedr.com/blog/marketing-sales-strategies-for-biotechs What is Capital Outlay?
https://www.excedr.com/blog/what-is-capital-outlay People Mentioned:Mike Long CEO
https://en.wikipedia.org/wiki/Mike_Long_(American_businessman)